Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales ...
The best bridge camera combines the convenience of a compact camera with the zoom of a telephoto lens and the ergonomics of a DSLR. In fact they look and feel pretty similar to a DSLR, but they have a ...
Abemaciclib (Verzenio / Verzenios / Yulareb / Zenlistik) is a benzimidazole derivative, acts as an anti-tumor or anti-neoplastic agent. It is formulated as tablets and film coated tablets for the oral ...
During a clinical trial, researchers found that CDK4/CDK6 inhibitor Verzenio may have a huge impact on women battling early stage breast cancer by decreasing the likelihood of the cancer returning.
Verzenio is a CDK4/CDK6 inhibitor which helps slow down the growth of cancer in women with HR-positive, HER-2 negative metastatic breast cancer. And now women with early-stage disease, regardless of ...
Scorpion has been collaborating with Pfizer to study STX-678 together with a so-called CDK4 inhibitor. Lilly sells a drug, called Verzenio, that similarly targets CDK4 alongside a related protein.
BALTIMORE -- The first steps in the reconstruction of the Francis Scott Key Bridge are set to begin later this week, according to the MDTA. Pre-construction activities were originally set to begin ...
The FDA has approved Lilly’s Verzenio, making it the third market entrant in a new class of drugs for breast cancer. Verzenio (abemaciclib) is now licensed to treat adult patients with hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results